Serum has 40m doses of Oxford vaccine ready

Serum has 40m doses of Oxford vaccine ready

TIMES NEWS NETWORK

New Delhi:13.11.2020

In order to ensure early availability of its Covid-19 vaccine once approved, Pune-based Serum Institute of India (SII) has already manufactured 40 million doses of the candidate developed by Oxford University and AstraZeneca, under the ‘atrisk’ manufacturing and stockpiling licence from the Indian drug regulator, reports Sushmi Dey.

The company plans to stockpile 200-300 million doses by January and around 50% of its capacity is expected to cater to local requirements, regulatory sources said.

Serum and Indian Council of Medical Research (ICMR) on Thursday said 1,600 participants have been enrolled in the Phase 3 clinical trials for the vaccine—Covishield— in the country and, based on the Phase 2/3 trial results, SII with the help of ICMR will also pursue early availability of this product for India. P 10